Novophage nabs $5.75M funding, names Rosenbloom as CEO

By Rodney H. Brown, Mass High Tech

Novophage Inc., a startup that was known until March as Novophage Therapeutics Inc., has taken in $5.75 million in its first institutional funding round. The deal also brings on Micah Rosenbloom, co-founder of Bronte Technologies, as CEO of the company…Founded in 2009 in Cambridge, and now using lab space at the University of Massachusetts Venture Development Center, Novophage is working to develop an anti-biofilm solution that is eco-friendly and highly effective, according to company officials…con’t

The Venture Development Center is Boston’s leading startup incubator for technology and life science companies.

Submit a Comment

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>